How macrocyclic drugs are gaining momentum in the cardiometabolic disease space
Discover biotech and big pharma’s emerging interest in developing macrocyclic drugs for cardiometabolic diseases.
Discover biotech and big pharma’s emerging interest in developing macrocyclic drugs for cardiometabolic diseases.